| RS116239086 |
CCBE1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1162394508 |
BRCA2
|
Health Risk |
Pathogenic |
Hereditary breast ovarian cancer syndrome, Breast-ovarian cancer |
| RS116239777 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Collagen 6-related myopathy, Bethlem myopathy 1A |
| RS1162414657 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS1162424416 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1162425274 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1162447958 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS116246250 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leber congenital amaurosis 8, Retinitis pigmentosa |
| RS1162464868 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS116247954 |
RTEL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal recessive 5 |
| RS1162493574 |
SPAST
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Hereditary spastic paraplegia 4 |
| RS1162494442 |
CHD5
|
Health Risk |
Likely pathogenic |
Global developmental delay, Seizure |
| RS1162522193 |
TCF20
|
Health Risk |
Likely pathogenic |
— |
| RS1162525540 |
CD151
|
Health Risk |
Conflicting classifications of pathogenicity |
RAPH BLOOD GROUP SYSTEM, Epidermolysis bullosa simplex 7 |
| RS1162525817 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), Peroxisome biogenesis disorder 11A (Zellweger) |
| RS1162526607 |
DNAH11
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 7 |
| RS1162530361 |
SLC12A6
|
Health Risk |
Pathogenic/Likely pathogenic |
Agenesis of the corpus callosum with peripheral neuropathy, Charcot-Marie-Tooth disease |
| RS1162532498 |
DNAH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1162534390 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS116253689 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS116254142 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS116254382 |
NDUFA10
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex I deficiency, nuclear type 1 |
| RS1162544118 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS1162552295 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Charcot-Marie-Tooth disease axonal type 2O |
| RS1162553327 |
NEB
|
Health Risk |
Pathogenic |
Nemaline myopathy 2, Arthrogryposis multiplex congenita 6 |
| RS116256579 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1162584542 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1162586274 |
PDZD7
|
Health Risk |
Pathogenic |
— |
| RS1162597563 |
COL11A1
|
Health Risk |
Pathogenic |
— |
| RS1162601696 |
COL4A4
|
Health Risk |
Pathogenic/Likely pathogenic |
Benign familial hematuria, Autosomal recessive Alport syndrome |
| RS116262072 |
BBS9
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 9 |
| RS1162633293 |
UMOD
|
Health Risk |
Likely pathogenic |
Familial juvenile hyperuricemic nephropathy type 1, Familial juvenile hyperuricemic nephropathy type 1 |
| RS1162635365 |
CSPP1
|
Health Risk |
Likely pathogenic |
Joubert syndrome 21, Joubert syndrome 21 |
| RS116263919 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, POLE-related disorder |
| RS1162641847 |
CEP83
|
Health Risk |
Pathogenic |
Nephronophthisis 18, Nephronophthisis 18 |
| RS116264627 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1162654150 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Hematuria, benign familial |
| RS1162659137 |
ATP7B
|
Health Risk |
Likely pathogenic |
Wilson disease, Wilson disease |
| RS1162661952 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Luscan-Lumish syndrome, Luscan-Lumish syndrome |
| RS1162671660 |
GALC
|
Health Risk |
Likely pathogenic |
Galactosylceramide beta-galactosidase deficiency, Galactosylceramide beta-galactosidase deficiency |
| RS1162681591 |
PDGFRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome, Acroosteolysis-keloid-like lesions-premature aging syndrome |
| RS116269563 |
PAPPA2
|
Health Risk |
Pathogenic |
— |
| RS1162696593 |
TNNI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1162711197 |
SETD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ovarian serous cystadenocarcinoma, Ovarian serous cystadenocarcinoma |
| RS1162732075 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1162745955 |
CFTR
|
Health Risk |
Conflicting classifications of pathogenicity |
Cystic fibrosis, Cystic fibrosis |
| RS1162750836 |
MFSD8
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS1162759892 |
HR
|
Health Risk |
Pathogenic |
— |
| RS1162767709 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1162770123 |
ORC1
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 1, Meier-Gorlin syndrome 1 |
| RS1162780893 |
SMAD9
|
Health Risk |
Pathogenic |
Pulmonary hypertension, primary |
| RS1162787335 |
SLC4A1
|
Health Risk |
Pathogenic |
Hereditary spherocytosis type 4, Hereditary spherocytosis type 4 |
| RS1162794351 |
SMPD1
|
Health Risk |
Likely pathogenic |
Niemann-Pick disease, type B |
| RS1162797495 |
RTN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Hereditary spastic paraplegia 12 |
| RS1162799877 |
ANK2
|
Health Risk |
Likely pathogenic |
ANK2-related disorder, ANK2-related disorder |
| RS1162806402 |
EYS
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 25, Retinitis pigmentosa 25 |
| RS1162809128 |
INTS1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with cataracts, poor growth |
| RS1162814122 |
MSH6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome 5 |
| RS1162823375 |
DNAH11
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1162831467 |
PAH
|
Health Risk |
Pathogenic/Likely pathogenic |
Phenylketonuria, Inborn genetic diseases |
| RS1162831950 |
CPT1A
|
Health Risk |
Pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS116283249 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Duchenne muscular dystrophy |
| RS1162846901 |
RAD50
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1162851273 |
ABCC6
|
Health Risk |
Pathogenic |
— |
| RS1162905063 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS1162933116 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1162942997 |
CAPN3
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Muscular dystrophy |
| RS1162948308 |
MMADHC
|
Health Risk |
Pathogenic/Likely pathogenic |
Methylmalonic aciduria and homocystinuria type cblD, Methylmalonic aciduria and homocystinuria type cblD |
| RS1162953058 |
OTUD7A
|
Health Risk |
Pathogenic |
Specific learning disability, Language disorder |
| RS1162953685 |
MCCC1
|
Health Risk |
Pathogenic |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS116297260 |
SPTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Elliptocytosis 2, Hereditary spherocytosis type 3 |
| RS116297894 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS116298211 |
AK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Spermatogenic failure 27, Spermatogenic failure 27 |
| RS1162988139 |
SLC27A5
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1162998218 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS1163007321 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS116300982 |
GUF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 40 |
| RS1163013218 |
COL3A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, type 4 |
| RS116302615 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Achondrogenesis, type IB |
| RS1163037065 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1163040913 |
RDH12
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa, Leber congenital amaurosis 13 |
| RS116304324 |
ZNF407
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1163046936 |
LINS1
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal recessive 27 |
| RS1163049039 |
PPM1D
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold, Intellectual developmental disorder with gastrointestinal difficulties and high pain threshold |
| RS1163061829 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS116306908 |
VLDLR
|
Health Risk |
Conflicting classifications of pathogenicity |
VLDLR-related disorder, Lung cancer |
| RS1163069592 |
TK2
|
Health Risk |
Pathogenic |
— |
| RS1163072872 |
ACAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1163089098 |
EYS
|
Health Risk |
Pathogenic |
— |
| RS1163091441 |
ALDOB
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary fructosuria, Hereditary fructosuria |
| RS116310349 |
TMPRSS6
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcytic anemia, TMPRSS6-related disorder |
| RS1163109289 |
SLC16A2
|
Health Risk |
Likely pathogenic |
— |
| RS1163121743 |
SLC34A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi renotubular syndrome 2, Hypercalcemia |
| RS116314059 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Nephronophthisis, INVS-related disorder |
| RS116314131 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Lynch syndrome |
| RS116314856 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, COG7 congenital disorder of glycosylation |
| RS116314916 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, Inborn genetic diseases |
| RS1163156807 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS116315896 |
PYGM
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type V |
| RS1163159065 |
GLDC
|
Health Risk |
Pathogenic |
Glycine encephalopathy, Glycine encephalopathy |